David Olsen

Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax.

T. Triglia, A. Cowman, W. Tham, 2022, Structure.

Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax.

T. Triglia, A. Cowman, J. McCauley, 2021, Structure.

Identification of an inhibitory pocket in falcilysin bound by chloroquine provides a new avenue for malaria drug development

P. Nordlund, Zbynek Bozdech, N. Prabhu, 2021, bioRxiv.

Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development

P. Nordlund, Zbynek Bozdech, N. Prabhu, 2021, bioRxiv.

2′-Modified Guanosine Analogs for the Treatment of HCV

Q. Dang, A. Stamford, Vishal A. Verma, 2016, Nucleosides, Nucleotides & Nucleic Acids.

Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.

D. Hazuda, C. Flexner, S. Swindells, 2018, The International Journal of Tuberculosis and Lung Disease.